Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Clerodendrum volubile aqueous extract is a botanical research compound derived from the leaves or flowers of the *Clerodendrum volubile* plant, native to West Africa. It is primarily investigated for its potential in managing type 2 diabetes and metabolic syndrome. The extract functions by inhibiting key carbohydrate-metabolizing enzymes, such as alpha-glucosidase and alpha-amylase, and exhibits significant antioxidant properties by scavenging free radicals and reducing lipid peroxidation. In traditional medicine, it is used for a variety of conditions including hypertension, arthritis, and obesity. Research has also highlighted its inhibitory effects on pancreatic lipase and glucose-6-phosphatase, suggesting a multi-target approach to metabolic regulation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on clerodendrum volubile aqueous extract.